.png){kind=small}
Obliterate catheter-associated infections
Benefits of infection prevention
Fewer Infections
Catheter-associated urinary tract infections are a leading cause of hospital infections, affecting up to 30% of catheterized patients. BaLu™ uses UV technology to prevent bacterial buildup, reducing infection risks and supporting safer patient outcomes.
Less Use of Antibiotics
Reducing catheter-associated urinary tract infections means fewer antibiotic treatments and a lower risk of antibiotic resistance and side effects. BaLu™ offers a proactive solution that helps limit antibiotic use, supporting long-term patient health and better hospital outcomes.
Better Care
With BaLu™, healthcare staff spend less time managing infections and more time on essential patient care. By reducing infection-related hospital stays, BaLu™ helps nurses and doctors focus on what matters most—providing dedicated, hands-on care to every patient.
At VIOBAC, we provide solutions to prevent catheter-associated infections (CAIs). Our mission is to create and deliver prophylactic solutions that enhance our patient's quality of life. Their health is our top priority.
VIOBAC unveils small, convenient, prophylactic medical devices tailored to combat the most common hospital-acquired infections. Our first product, BaLu™, targets catheter-associated urinary tract infections (CAUTIs) and represents the first step toward our broader vision of offering solutions for additional CAIs.
Latest News
Date
Viobac Launches Clinical Multicenter Study
In November 2024, Viobac initiated a clinical multicenter study at Herlev and Glostrup-Rigshospitalet.
Go to news sections